Artiva Biotherapeutics awarded Chief Medical Officer Banerjee Subhashis 30,000 shares at $0 per share on September 9, 2026, along with 85,000 derivative securities. The transactions raised his resulting holdings to 170,947 shares and 85,000 derivative securities, giving investors a clear view of the reported insider award and ownership position.

Key Highlights

  • Banerjee Subhashis held 170,947 Artiva Biotherapeutics shares after the award.
  • The Chief Medical Officer received 85,000 derivative securities in a separate award.
  • The 30,000-share transaction represented about 17.5% of his resulting shareholding.

Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) awarded Chief Medical Officer Banerjee Subhashis 30,000 shares at $0 per share on September 9, 2026. The same date also brought an award of 85,000 derivative securities.

September 9 Awards Add Shares and Derivative Securities

Banerjee’s resulting Artiva Biotherapeutics shareholding stood at 170,947 shares after the transaction. The share award represented about 17.5% of that resulting holding. Banerjee held 85,000 derivative securities following that transaction, representing about 100.0% of his resulting derivative-securities holding.

Resulting Insider Ownership Position

His post-transaction share total was 170,947, while his derivative-securities holding was 85,000. The filing classifies both transactions as awards made on September 9, 2026.